In addition, administration of biologically active protein obtained from organisms other than human, such as microorganisms or animals, to human, may result in critical symptoms due to the immune reaction Therefore, technology development is desired which delays the rate of elimination of the protein from the body and which further reduces immunogenicity (antigenicity) thereof while activity is re